InfuSystem Holdings, Inc. filed a current report on October 27, 2026, announcing that it will release its third-quarter 2026 financial results and host an investor conference call on November 3, 2026.

Key Highlights

  • Results date: InfuSystem will disclose its third-quarter 2026 financial results on Tuesday, November 3, 2026, before the market opens.
  • Conference call scheduled: An investor conference call is set for November 3, 2026 at 9:00 a.m. Eastern Time.
  • Regulation FD disclosure: The announcement was made under Item 7.01, Regulation FD, and the press release is furnished as Exhibit 99.1.
  • Signatory: The filing was signed by Carrie Lachance, Chief Executive Officer and Director of InfuSystem Holdings, Inc.
  • Exchange listing: InfuSystem common stock trades on NYSE American under the symbol INFU (NYSE American:INFU), with a par value of $0.0001 per share.

InfuSystem Announces Third-Quarter 2026 Earnings Schedule and Investor Call

InfuSystem Holdings, Inc., a Delaware-incorporated company headquartered at 3851 West Hamlin Road, Rochester Hills, Michigan, filed a current report on October 27, 2026, under Item 7.01 (Regulation FD Disclosure). According to the filing, the company issued a press release on that same date informing investors that it will publish its financial results for the third quarter of 2026 before the opening of markets on November 3, 2026. The press release was furnished as Exhibit 99.1 to the filing.

The filing also disclosed that InfuSystem will hold a conference call open to all interested investors on November 3, 2026, beginning at 9:00 a.m. Eastern Time. The company, which provides infusion services and related medical equipment, signed the filing through its Chief Executive Officer and Director, Carrie Lachance. The filing notes that information furnished under Item 7.01 and in the attached press release "shall not be deemed 'filed' for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended," and is not incorporated by reference into the company's other filings under either the Securities Act of 1933 or the Securities Exchange Act of 1934.

What Was Disclosed

InfuSystem Holdings, Inc. disclosed via a current report filed October 27, 2026, that it will release third-quarter 2026 financial results and host an investor conference call before market open on November 3, 2026, with the press release furnished as Exhibit 99.1.